Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

E-coli Testing Market by Test (Environmental Test, Clinical Test) , by End User (Hospitals, Diagnostic Laboratories, Physicians Offices) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A11131

Pages: 240

Charts: 54

Tables: 108

E-Coli Testing Market Research, 2033

The global e-coli testing market was valued at $2.1 billion in 2023, and is projected to reach $3.9 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033. Rise in the incidences of food-borne illnesses, technological advancements, and consumer awareness are the primary drivers of the market.

Market Introduction and Definition 

E-coli testing refers to the process of detecting the presence of Escherichia coli (e-coli) bacteria in various samples, such as food, water, clinical specimens, or environmental samples. It is a type of bacteria that is frequently discovered in both human and animal intestines. Many e-coli strains are benign, but some can cause anything from minor gastrointestinal discomfort to serious infections. E-coli testing is done in clinical settings to identify infections brought on by pathogenic strains of the bacteria. Urinary tract infections (UTIs) , sepsis, newborn meningitis, and gastrointestinal illnesses (such diarrhea) are among the common infections. To isolate and identify the bacteria, testing may require cultivating clinical materials such as urine, feces, blood, or cerebrospinal fluid. 

 Key Takeaways 

  • The e-coli testing market size study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period. 
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major e-coli testing industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights. 
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives. 

 Key Market Segments

  • By Test
    • Environmental Test
    • Clinical Test
  • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Physicians Offices
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Thermo Fisher Scientific Inc
  • Alere Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Pro Lab diagnostics
  • CPI International
  • Bio-Rad Laboratories, Inc.
  • Nano Logix Inc
  • Meridian Bioscience Inc.
  • IDEXX Laboratories, Inc.

 
Other Players

  • NanoLogix, Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: E-COLI TESTING MARKET, BY TEST

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Test

    • 4.2. Environmental Test

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Clinical Test

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: E-COLI TESTING MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Diagnostic Laboratories

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Physicians Offices

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: E-COLI TESTING MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Test

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. E-coli Testing Market

        • 6.2.5.1. Market Size and Forecast, By Test
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada E-coli Testing Market

        • 6.2.6.1. Market Size and Forecast, By Test
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico E-coli Testing Market

        • 6.2.7.1. Market Size and Forecast, By Test
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Test

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France E-coli Testing Market

        • 6.3.5.1. Market Size and Forecast, By Test
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany E-coli Testing Market

        • 6.3.6.1. Market Size and Forecast, By Test
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy E-coli Testing Market

        • 6.3.7.1. Market Size and Forecast, By Test
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain E-coli Testing Market

        • 6.3.8.1. Market Size and Forecast, By Test
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK E-coli Testing Market

        • 6.3.9.1. Market Size and Forecast, By Test
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia E-coli Testing Market

        • 6.3.10.1. Market Size and Forecast, By Test
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe E-coli Testing Market

        • 6.3.11.1. Market Size and Forecast, By Test
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Test

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China E-coli Testing Market

        • 6.4.5.1. Market Size and Forecast, By Test
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan E-coli Testing Market

        • 6.4.6.1. Market Size and Forecast, By Test
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India E-coli Testing Market

        • 6.4.7.1. Market Size and Forecast, By Test
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea E-coli Testing Market

        • 6.4.8.1. Market Size and Forecast, By Test
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia E-coli Testing Market

        • 6.4.9.1. Market Size and Forecast, By Test
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand E-coli Testing Market

        • 6.4.10.1. Market Size and Forecast, By Test
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia E-coli Testing Market

        • 6.4.11.1. Market Size and Forecast, By Test
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia E-coli Testing Market

        • 6.4.12.1. Market Size and Forecast, By Test
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific E-coli Testing Market

        • 6.4.13.1. Market Size and Forecast, By Test
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Test

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil E-coli Testing Market

        • 6.5.5.1. Market Size and Forecast, By Test
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa E-coli Testing Market

        • 6.5.6.1. Market Size and Forecast, By Test
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia E-coli Testing Market

        • 6.5.7.1. Market Size and Forecast, By Test
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE E-coli Testing Market

        • 6.5.8.1. Market Size and Forecast, By Test
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina E-coli Testing Market

        • 6.5.9.1. Market Size and Forecast, By Test
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA E-coli Testing Market

        • 6.5.10.1. Market Size and Forecast, By Test
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Thermo Fisher Scientific Inc

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. IDEXX Laboratories, Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Becton, Dickinson And Company

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Meridian Bioscience Inc.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Bio-Rad Laboratories, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Alere Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. CPI International

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. BioMérieux SA

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Pro Lab Diagnostics

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Nano Logix Inc

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL E-COLI TESTING MARKET, BY TEST, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL E-COLI TESTING MARKET FOR ENVIRONMENTAL TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL E-COLI TESTING MARKET FOR CLINICAL TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL E-COLI TESTING MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL E-COLI TESTING MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL E-COLI TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL E-COLI TESTING MARKET FOR PHYSICIANS OFFICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL E-COLI TESTING MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA E-COLI TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. U.S. E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 13. U.S. E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. CANADA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 15. CANADA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE E-COLI TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. ITALY E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 26. ITALY E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. UK E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 30. UK E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC E-COLI TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. CHINA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 39. CHINA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. INDIA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 43. INDIA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA E-COLI TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. UAE E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 66. UAE E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA E-COLI TESTING, BY TEST, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA E-COLI TESTING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. THERMO FISHER SCIENTIFIC INC: KEY EXECUTIVES
  • TABLE 72. THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT
  • TABLE 73. THERMO FISHER SCIENTIFIC INC: OPERATING SEGMENTS
  • TABLE 74. THERMO FISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
  • TABLE 75. THERMO FISHER SCIENTIFIC INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. IDEXX LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 77. IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 78. IDEXX LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 79. IDEXX LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 80. IDEXX LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 82. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 83. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 84. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 85. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. MERIDIAN BIOSCIENCE INC.: KEY EXECUTIVES
  • TABLE 87. MERIDIAN BIOSCIENCE INC.: COMPANY SNAPSHOT
  • TABLE 88. MERIDIAN BIOSCIENCE INC.: OPERATING SEGMENTS
  • TABLE 89. MERIDIAN BIOSCIENCE INC.: PRODUCT PORTFOLIO
  • TABLE 90. MERIDIAN BIOSCIENCE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 92. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 93. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 94. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 95. BIO-RAD LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. ALERE INC.: KEY EXECUTIVES
  • TABLE 97. ALERE INC.: COMPANY SNAPSHOT
  • TABLE 98. ALERE INC.: OPERATING SEGMENTS
  • TABLE 99. ALERE INC.: PRODUCT PORTFOLIO
  • TABLE 100. ALERE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. CPI INTERNATIONAL: KEY EXECUTIVES
  • TABLE 102. CPI INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 103. CPI INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 104. CPI INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 105. CPI INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. BIOMéRIEUX SA: KEY EXECUTIVES
  • TABLE 107. BIOMéRIEUX SA: COMPANY SNAPSHOT
  • TABLE 108. BIOMéRIEUX SA: OPERATING SEGMENTS
  • TABLE 109. BIOMéRIEUX SA: PRODUCT PORTFOLIO
  • TABLE 110. BIOMéRIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. PRO LAB DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 112. PRO LAB DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 113. PRO LAB DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 114. PRO LAB DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 115. PRO LAB DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. NANO LOGIX INC: KEY EXECUTIVES
  • TABLE 117. NANO LOGIX INC: COMPANY SNAPSHOT
  • TABLE 118. NANO LOGIX INC: OPERATING SEGMENTS
  • TABLE 119. NANO LOGIX INC: PRODUCT PORTFOLIO
  • TABLE 120. NANO LOGIX INC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL E-COLI TESTING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL E-COLI TESTING MARKET
  • FIGURE 3. SEGMENTATION E-COLI TESTING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN E-COLI TESTING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALE-COLI TESTING MARKET
  • FIGURE 11. E-COLI TESTING MARKET SEGMENTATION, BY BY TEST
  • FIGURE 12. E-COLI TESTING MARKET FOR ENVIRONMENTAL TEST, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. E-COLI TESTING MARKET FOR CLINICAL TEST, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. E-COLI TESTING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. E-COLI TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. E-COLI TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. E-COLI TESTING MARKET FOR PHYSICIANS OFFICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: E-COLI TESTING MARKET
  • FIGURE 24. TOP PLAYER POSITIONING, 2024
  • FIGURE 25. THERMO FISHER SCIENTIFIC INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 26. THERMO FISHER SCIENTIFIC INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 27. THERMO FISHER SCIENTIFIC INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 28. IDEXX LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. IDEXX LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. IDEXX LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. BECTON, DICKINSON AND COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. MERIDIAN BIOSCIENCE INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. BIO-RAD LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. ALERE INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. ALERE INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. ALERE INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. CPI INTERNATIONAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. CPI INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. CPI INTERNATIONAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. BIOMéRIEUX SA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. BIOMéRIEUX SA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. BIOMéRIEUX SA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. PRO LAB DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. PRO LAB DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. PRO LAB DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. NANO LOGIX INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. NANO LOGIX INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. NANO LOGIX INC: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
E-coli Testing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved